The quadrivalent HPV vaccine is protective against genital warts: a meta-analysis
Background The quadrivalent human papillomavirus (HPV) vaccine has been assumed to
give protection against genital warts (GW) as well as cervical cancer. Our main question was …
give protection against genital warts (GW) as well as cervical cancer. Our main question was …
Potential impact of human papillomavirus vaccines on public STD clinic workloads and on opportunities to diagnose and treat other sexually transmitted diseases
AF Dempsey, LA Koutsky, M Golden - Sexually transmitted …, 2007 - journals.lww.com
Background: Eradicating genital warts through HPV immunization could decrease STD clinic
utilization but may result in missed opportunities to diagnose other STDs. Objectives: To …
utilization but may result in missed opportunities to diagnose other STDs. Objectives: To …
[HTML][HTML] Human papillomavirus vaccination coverage in Luxembourg–Implications of lowering and restricting target age groups
Abstract Background In Luxembourg, a national Human Papillomavirus (HPV) vaccination
programme was introduced in 2008, targeting 12–17 year old girls offering a choice of …
programme was introduced in 2008, targeting 12–17 year old girls offering a choice of …
Patterns of incident genital human papillomavirus infection in women: A literature review and meta-analysis
BS Wheeler, AF Rositch, C Poole… - … journal of STD & …, 2019 - journals.sagepub.com
Human papillomavirus (HPV) infection acquisition is a necessary step in the development of
cervical cancer. No study has systematically quantified the rate of newly acquired HPV …
cervical cancer. No study has systematically quantified the rate of newly acquired HPV …
Cost of preventing, managing, and treating human papillomavirus (HPV)-related diseases in Sweden before the introduction of quadrivalent HPV vaccination
E Östensson, M Fröberg, A Leval, AC Hellström… - PloS one, 2015 - journals.plos.org
Objective Costs associated with HPV-related diseases such as cervical dysplasia, cervical
cancer, and genital warts have not been evaluated in Sweden. These costs must be …
cancer, and genital warts have not been evaluated in Sweden. These costs must be …
Actions improving HPV vaccination uptake–Results from a national survey in Italy
C Giambi, M Del Manso, F D'Ancona, B De Mei… - Vaccine, 2015 - Elsevier
Abstract Background In Italy, HPV vaccination is offered to 11-year-old girls since 2007. In
2012 coverage was 69%. Strategies for offering and promoting HPV vaccination and …
2012 coverage was 69%. Strategies for offering and promoting HPV vaccination and …
Infections in temporal proximity to HPV vaccination and adverse effects following vaccination in Denmark: A nationwide register-based cohort study and case …
Background Public trust in the human papilloma virus (HPV) vaccination programme has
been challenged by reports of potential severe adverse effects. The reported adverse …
been challenged by reports of potential severe adverse effects. The reported adverse …
Estimating the burden of illness related to genital warts in the Philippines: a nationally representative cross-sectional study
L Buenconsejo, S Kothari-Talwar, K Yee… - Infectious Agents and …, 2019 - Springer
Background This study estimated genital warts prevalence, genital-warts-related healthcare
resource use and costs, and self-reported human-papillomavirus-related psychosocial …
resource use and costs, and self-reported human-papillomavirus-related psychosocial …
Health service utilisation for anogenital warts in Ontario, Canada prior to the human papillomavirus (HPV) vaccine programme introduction: a retrospective …
FM Guerra, LC Rosella, S Dunn, SE Wilson, C Chen… - BMJ open, 2016 - bmjopen.bmj.com
Objective Trends in occurrence of anogenital warts (AGWs) can provide early evidence of
human papillomavirus (HPV) vaccination programme impact on preventing HPV infection …
human papillomavirus (HPV) vaccination programme impact on preventing HPV infection …
Assessing incidence and economic burden of genital warts with data from a US commercially insured population
T Hoy, PK Singhal, VJ Willey… - Current medical research …, 2009 - Taylor & Francis
Objective: This study examined the incidence of and healthcare costs attributable to genital
warts within a large US commercially insured, geographically dispersed population …
warts within a large US commercially insured, geographically dispersed population …